Circulating growth differentiation factor 15 levels and apolipoprotein b to apolipoprotein a1 ratio in coronary artery disease patients with type 2 diabetes mellitus

HIGHLIGHTS

• who: Yufeng Mei from the All participants in this study were recruited from the Department of Cardiovascular Medicine and Endocrinology, Renmin Hospital of Wuhan UniversityPast medical history, lifestyle, and drug use of all patients were obtained before their admission. T DM patients with or without CAD were all eligible for the study and consecutive patients were also included. The following are exclusion criteria: (1) malignancy and undergoing have published the research: Circulating growth differentiation factor 15 levels and apolipoprotein B to apolipoprotein A1 ratio in coronary artery disease patients with type 2 diabetes mellitus, in the Journal . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.